Related and Nonrelated Parties [Axis] Related Party [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Series Convertible Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Merger Agreement [Member] Ownership [Axis] Polomar Specialty Pharmacy LLC [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Customer [Member] Accounts Receivable [Member] One Customer [Member] Two Customer [Member] Debt Instrument [Axis] Reprise Note [Member] Promissory Note and Loan Agreement [Member] Series A Convertible Preferred Stock [Member] Investment, Name [Axis] Mr. Gordon [Member] CWR 1 LLC [Member] Statistical Measurement [Axis] Maximum [Member] CWR Note II [Member] CWR II First Amendment [Member] Business Combination [Axis] Profesco Note [Member] Orion Specialty Labs LLC [Member] Common Stock One [Member] Title and Position [Axis] Board of Directors Chairman [Member] Common Stock Two [Member] CWR 1, LLC [Member] Reprise Management, Inc [Member] Plan Name [Axis] 2024 Plan [Member] 2022 Equity Incentive Plan [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Product and Service [Axis] Prescription Fulfillment [Member] Others [Member] Terrence M Tierney [Member] Amended Agreement [Member] Minimum [Member] Award Type [Axis] Non Qualified Stock Option [Member] License Agreement [Member] Intangible Asset, Finite-Lived, Class [Axis] Intellectual Property [Member] ForHumanity Agreement [Member] Distribution Agreement [Member] Mr. Tierney [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] ASSETS Current assets Cash Accounts receivable Inventory Other current assets Total current assets Property and equipment, net Operating lease - right-of-use asset Security deposit Total assets LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities and total liabilities Accounts payable and accrued liabilities Unearned revenue Promissory notes – related parties Operating lease - current liability Other current liabilities Total liabilities Commitment and Contingencies Note 8 Stockholders’ deficit Series A convertible preferred stock, par value $.001; 5,000,000 shares authorized; 161 and 150 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. Common stock; $0.001 par value; 295,000,000 shares authorized; 28,280,868 and 28,019,624 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively. Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total Liabilities and Stockholders’ Deficit Statement [Table] Statement [Line Items] Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue Cost of goods sold Gross profit Operating expenses General and administrative Sales and marketing Total operating expenses Income (loss) from operations Other expense Interest expense Total other expense Net income (loss) Dividend on Series A convertible preferred stock Net income (loss) attributable to common stockholders Net income (loss) per common share: basic Weighted average common shares outstanding – basic Weighted average common shares outstanding – diluted Balance Balance, shares Stock-based compensation that was previously accrued for Stock-based compensation that was previously accrued for, shares Issuance of Series A convertible preferred stock related to dividend Issuance of Series A convertible preferred stock related to dividend, shares Dividend paid and accrued Net loss Conversion of Series A preferred stock Conversion of Series A preferred stock, shares Issuance of common stock Issuance of common stock, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Net income (loss) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization Stock-based compensation Changes in operating assets and liabilities Accounts receivable Other current assets Inventory Unearned revenue Accounts payable and accrued liabilities Net cash provided by (used) in operating activities Cash flows from investing activities Net cash provided by (used in) investing activities Cash Flows from Financing Activities Proceeds from related party Payments on promissory notes – related parties Proceeds from promissory notes – related party Dividend paid Net cash (used in) provided by financing activities Net increase (decrease) in cash Cash, beginning of period Cash, end of period Supplemental disclosure of non-cash investing and financing activities Stock-based compensation that was previously accrued for Paid-in-kind dividend Series A Convertible preferred stock dividend Supplemental disclosure of cash flow information Cash paid for interest Accounting Policies [Abstract] NATURE AND DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Equity [Abstract] STOCKHOLDERS’ DEFICIT Earnings Per Share [Abstract] EARNINGS PER SHARE Fair Value Disclosures [Abstract] REVENUE Lease LEASE Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Consolidation Going Concern and Liquidly Use Of Estimates Cash and Cash Equivalents. Inventory Earnings Per Share Revenue Recognition Fair Value Measurements Income Taxes Segment Reporting Concentration Adopted Accounting Pronouncements Recent Accounting Pronouncements SCHEDULE OF LOSS PER SHARE BASIC AND DILUTED SCHEDULE OF DISAGGREGATED OF REVENUE SCHEDULE OF LEASE COST SCHEDULE OF LEASE ACTIVITY FOR RIGHT OF USE ASSET Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Common stock, shares returned for cancellation Shares of common stock issued in merger Nature of Operation, Product Information, Concentration of Risk [Table] Product Information [Line Items] Minority interest percentage Accumulated deficit Cash equivalents Uncertain tax position Concentration risk, percentage Related Party Transaction [Table] Related Party Transaction [Line Items] Debt principal amount Initial draw Notes payable Interest Payable, Current Debt Conversion, Original Debt, Amount Shares issued upon exchange Debt Instrument, Interest Rate, Stated Percentage Equity Method Investment, Ownership Percentage Long-Term Debt Initial interest rate Note principal amount Discount interest rate [custom:DebtInstrumentWithdrawnAmount] Repayments of Related Party Debt Sale of Stock, Percentage of Ownership after Transaction Voting rights Maximum borrowing amount Number of doses Related Party Transaction, Purchases from Related Party Number of sample product Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common Stock, Shares Authorized Common Stock, Par or Stated Value Per Share Common Stock, Shares, Outstanding Stock Issued During Period, Shares, Issued for Services Share price Dividends, Preferred Stock, Paid-in-kind Dividends, Preferred Stock, Cash Share issued upon conversion Reserved stock Annual automatic increase percentage Net income (loss) Dividend on Series A Preferred Net income (loss) attributable for common shareholders Weighted average shares outstanding - basic Weighted average shares outstanding - diluted Basic net income (loss) per share Diluted net income (loss) per share Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenue Schedule Of Lease Cost Lease cost Schedule Of Lease Activity For Right Of Use Asset Beginning balance Amortization charge for the period Ending balance Weighted average remaining lease term in years Weighed average discount rate Operating lease - right-of-use asset, net Loss Contingencies [Table] Loss Contingencies [Line Items] Salary and Wage, Officer, Excluding Cost of Good and Service Sold Fundraising threshold for salary increase Stock vested Vested exercise price Granted shares Exercise price Remaining vested shares percentage License agreements percentage of royalty payments License net present value Guaranteed payment Average monthly sales Gross revenues Forbearance payments Damage value Demanded payment for damages Subsequent Event [Table] Subsequent Event [Line Items] Vesting right description Stock Issued During Period, Shares, New Issues Payments for Rent Stock Purchase Agreement [Member] Series A Convertible Preferred Stock [Member] Merger Agreement [Member] Substantial Doubt About Going Concern [Policy Text Block] Customer [Member] One Customer [Member] 2022 Equity Incentive Plan [Member] Annual automatic increase percentage. Prescription Fulfillment [Member] Others [Member] Reprise Note [Member] Promissory Note and Loan Agreement [Member] Reprise Management, Inc [Member] CWR 1 LLC [Member] CWR Note II [Member] CWR II First Amendment [Member] Debt instrument discount percentage. Debt instrument withdrawn amount CWR 1, LLC [Member] Profesco Note [Member] Orion Specialty Labs LLC [Member] Guaranteed payment. Average monthly sales per month. ForHumanity Agreement [Member] Revenue gross. Rorbearance payments. Distribution Agreement [Member] License agreements percentage of royalty payments. License Agreement [Member] Proceeds from related party. Adopted Accounting Pronouncements [Policy Text Block] Five-month Period [Member[ Ten-year Non-qualified Options [Member] Mr. Tierney [Member] Revenue [Text Block] Common Stock One [Member] Common Stock Two [Member] Polomar Specialty Pharmacy LLC [Member] Number of product. 2024 Plan [Member] Mr. Gordon [Member] Number of sample product. Dividends preferred stock shares. Stock based compensation previously accrued. Remaining vested shares percentage. Stock issued during period shares stock dividend. Assets, Current Assets Liabilities Equity, Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Nonoperating Nonoperating Income (Expense) Redeemable Preferred Stock Dividends Shares, Outstanding Dividends, Cash Increase (Decrease) in Accounts Receivable Increase (Decrease) in Other Current Assets Increase (Decrease) in Inventories Increase (Decrease) in Deferred Revenue Increase (Decrease) in Accounts Payable and Accrued Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Payments of Dividends Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation StockbasedCompensationPreviouslyAccrued Inventory, Policy [Policy Text Block] Revenue from Contract with Customer, Including Assessed Tax Operating Lease, Right-of-Use Asset, Periodic Reduction